BioSpace News Archive

China Pharma Holdings, Inc., an NYSE American-listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based in China, announced the launch of N95 medical protective mask.

Cardio Diagnostics Holdings Inc, a leading precision cardiovascular diagnostics company, and Houston Concierge Medicine, a leading medical practice serving executives and health-forward consumers in Houston, announced the use of Cardio Diagnostics’ Epi+Gen CHD test.

CVRx, Inc., a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, announced that the management team will participate in the 41st Annual J.P. Morgan Healthcare Conference on Wednesday, January 11, 2023.

Aridis Pharmaceuticals, Inc. will host a conference call and audio-only webcast on Wednesday, January 25, at 4:15 p.m. ET to provide a business and pipeline update, including a discussion of topline data from the Company’s Phase 3 study of AR-301 in adjunctive treatment of S. aureus ventilator associated pneumonia.

Biomica Ltd. and a subsidiary of Evogene Ltd., announced it will be in attendance at the Healthcare Week taking place together with the J.P. Morgan Healthcare Conference in San Francisco.

Boundless Bio. announced that its Chief Executive Officer, Zachary Hornby, will present at the 41st Annual J.P. Morgan Healthcare Conference which will take place in San Francisco.

Alzamend Neuro, Inc. announced that it is partnering with the Miller School of Medicine, Interdisciplinary Stem Cell Institute at the University of Miami for its Phase I/IIA clinical trial of ALZN002, a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient’s immunological system to combat Alzheimer’s.

CEL-SCI Corporation reported financial results for the fiscal year ended September 30, 2022, as well as key clinical and corporate developments.

Varex Imaging Corporation announced that it is scheduled to present at CJS Securities 23rd Annual New Ideas for the New Year virtual investor conferences.

Biostage, Inc. announced that it had selected IQVIA, a leading global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry, as the contract research organization to manage its first clinical trial.